The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast

Pathology Research and Practice

Volumn 206, Issue 12, 2010, Pages 828-834

  Li, Weidong ^a   Liu, Fangfang ^a   Lei, Ting ^a   Xu, Xinsheng ^a   Liu, Bingbing ^a   Cui, Lifang ^a   Wei, Jia ^a   Guo, Xiaojing ^a   Lang, Ronggng ^a   Fan, Yu ^a   Gu, Feng ^a   Tang, Ping ^b   Zhang, Xinmin ^c   Fu, Li ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Breast cancer; Invasive micropapillary carcinoma of the breast; Stem cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD24 ANTIGEN; HERMES ANTIGEN; VIMENTIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; PHENOTYPE; PREVALENCE; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL;

EID: 78649719820     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.09.008     Document Type: Article

References (27)

1. Marx J. Cancer research. Mutant stem cells may seed cancer. Science 2003, 301:1308-1310.
2. Chen L., Fan Y., Lang R.G., Guo X.J., Sun Y.L., Cui L.F. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Int. J. Surg. Pathol. 2008, 16:155-163.
3. Guo X.J., Chen L., Lang R.G., Fan Y., Zhang X.M., Fu L. Invasive micropapillary carcinoma of the breast: association of pathologic features with lymph node metastasis. Am. J. Clin. Pathol. 2006, 126:740-746.
4. Middleton L.P., Tressera F., Sobel M.E., Bryant B.R., Alburquerque A., Grases P. Infiltrating micropapillary carcinoma of the breast. Mod. Pathol. 1999, 12:499-504.
5. Walsh M.M., Bleiweiss I.J. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum. Pathol. 2001, 32:583-589.
6. Siriaunkgul S., Tavassoli F.A. Invasive micropapillary carcinoma of the breast. Mod. Pathol. 1993, 6:660-662.
7. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. 2003, 100:3983-3988.
8. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005, 65:5506-5511.
9. +/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 2006, 8:R59.
10. + cells to blame?. Breast Cancer Res. 2010, 12:105.
11. Chuthapisith S., Eremin J., El-Sheemey M., Eremin O. Breast cancer chemoresistance: emerging importance of cancer stem cells. Surg. Oncol. 2010, 19:27-32.
12. +/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin. Cancer Res. 2005, 11:1154-1159.
13. Christiansen J.J., Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006, 66:8319-8326.
14. Fan Y., Lang R.G., Wang Y., Sun B.C., Fu L. Relationship between expression of cell adhesion molecules and metastatic potential in invasive micropapillary carcinoma of breast. Zhonghua Bing Li Xue Za Zhi 2004, 33:308-311.
15. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
16. Morel A.P., Lievre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008, 3:e2888.
17. Tavassaoeli F.A., Davilee P. Tumors of the Breast and Female Genital Organs, Classification of Tumours, No 4 2003, IARC WHO, Lyon.
18. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410.
19. Wei J., Cui L.F., Liu F., Fan Y., Lang R.G., Gu F. E-selectin and Sialyl Lewis X expression is associatedwith lymph node metastasis of invasivemicropapillary carcinoma of the breast. Int. J. Surg. Pathol. 2010, 18:193-200.
20. +/CD24-phenotype is enriched in basal-like breast tumors. Breast Cancer Res. 2008, 10:R53.
21. Wolff A.C., Hammond M.E., Schwartz J.N., Hagerty K.L., Allred D.C., Cote R.J. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J. Clin. Oncol. 2007, 25:118-145.
22. Ailles L.E., Weissman I.L. Cancer stem cells in solid tumors. Curr. Opin. Biotechnol. 2007, 18:460-466.
23. + tumor cells in invasive breast carcinomas. Hum. Pathol. 2008, 39:1096-1102.
24. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 2003, 15:740-746.
25. Kay R., Rosten P.M., Humphries R.K. CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor. J. Immunol. 1991, 147:1412-1416.
26. Baumann P., Cremers N., Kroese F., Orend G., Chiquet-Ehrismann R., Uede T. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res. 2005, 65:10783-10793.
27. Kristiansen G., Winzer K.J., Mayordomo E., Bellach J., Schlüns K., Denkert C. CD24 expression is a new prognostic marker in breast cancer. Clin. Cancer Res. 2003, 9:4906-4913.